Page last updated: 2024-10-24

cetyltrimethylammonium ion and Diabetes Mellitus, Type 2

cetyltrimethylammonium ion has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Khan, JM1
Malik, A1
Alresaini, SM1

Other Studies

1 other study available for cetyltrimethylammonium ion and Diabetes Mellitus, Type 2

ArticleYear
Molecular mechanism of insulin aggregation in the presence of a cationic surfactant.
    International journal of biological macromolecules, 2023, Mar-01, Volume: 230

    Topics: Cetrimonium; Diabetes Mellitus, Type 2; Humans; Insulin; Surface-Active Agents

2023